Improved chemical strategies for the targeted therapy of cancer.
Maison
Wolfgang
W
Institut für Organische Chemie, Universität Hamburg, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany. maison@chemie.uni-hamburg.de
Frangioni
John V
JV
D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use; D001952:Bridged-Ring Compounds / Q000008:administration & dosage / Q000737:chemistry; D004317:Doxorubicin / Q000008:administration & dosage / Q000737:chemistry; D004337:Drug Carriers / Q000493:pharmacokinetics; D016503:Drug Delivery Systems; D006801:Humans; D008024:Ligands; D008333:Mandelic Acids / Q000737:chemistry / Q000493:pharmacokinetics; D009369:Neoplasms / Q000188:drug therapy*; D009842:Oligopeptides / Q000008:administration & dosage / Q000737:chemistry; D017239:Paclitaxel / Q000008:administration & dosage / Q000737:chemistry; D043823:Taxoids / Q000008:administration & dosage / Q000737:chemistry
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; D004337:Drug Carriers; D008024:Ligands; D008333:Mandelic Acids; D009842:Oligopeptides; D043823:Taxoids; C014600:4-hydroxymandelic acid; D004317:Doxorubicin; C404743:IDN 5109; D017239:Paclitaxel